« Kerry Health Care Speech | Main | It's A Bird - Part III »
May 12, 2004
Amarin Gives 1Q Earnings
Amarin, the company with a Phase III Huntington's Disease drug, has announced their 1Q earnings.
The good news is that they are still in business. The bad news is that they don't have any income at the moment. At least this will motivate them to conduct and complete the (very) delayed Phase III trial of LAX-101, a fish-oil derivative. Not much else of interest in their press release but you can read it here.
Posted by Dave at May 12, 2004 07:39 PM
Trackback Pings
TrackBack URL for this entry:
http://www.huntingtons.info/MT/mt-tb.cgi/432
Comments
Post a comment
Thanks for signing in, . Now you can comment. (sign out)
(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)